ImmunityBio, Inc. — Director's Dealing 2020

Aug 13, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NantKwest, Inc. (NK)
CIK: 0001326110
Period of Report: 2020-08-11

Reporting Person: DRISCOLL FREDERICK W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-11	Common Stock	S	50000	$10.224	Disposed	124535	Direct
2020-08-11	Common Stock	S	10000	$9.9787	Disposed	114535	Direct
2020-08-11	Common Stock	S	5300	$10.7669	Disposed	109235	Direct

Footnotes

F1: Sales made in order to satisfy tax payments paid, accrued and/or owed by the reporting person.

F2: Represents the weighted average share price of an aggregate total of 50,000 shares sold in the price range of $9.89 to $10.7275 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Represents the weighted average share price of an aggregate total of 10,000 shares sold in the price range of $9.94 to $10.0301 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F4: Represents the weighted average share price of an aggregate total of 5,300 shares sold in the price range of $10.50 to $11.07 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.